holmes on stage development limited liability company

550 west 54th street
unit 1935
new york, new york 10019

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 30, 2013

NYS DOS ID#
4410671

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
ANTONIO R MARION
550 WEST 54TH STREET
UNIT 1935
NEW YORK, NEW YORK, 10019

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - HOLMES ON STAGE DEVELOPMENT LIMITED LIABILITY COMPANY









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Woody Allen’s ‘Wonder Wheel’ set to close NY Film Festival
    By Deadline - Tuesday Jul 25, 2017

    The film will go into limited release December 1.

    Source: New York Post: Entertainment
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Katie Holmes to star in adaptation of ‘The Secret’
    By Variety - Wednesday Aug 9, 2017

    The book postulated that human beings can control the universe with their minds and manifest their desires through the “law of attraction.”

    Source: New York Post: Entertainment
  • Twitter’s new premium APIs give developers access to more tweets, higher rate limits
    By Ken Yeung - Tuesday Nov 14, 2017

    Twitter is offering a solution for developers who are angry about limitations imposed on their apps when they use the service’s free APIs. The company has now introduced premium APIs to bridge the gap between the free service and the enterprise-level tools it provides through Gnip. Available today in public beta is the first tool […]

    Source: VentureBeat
  • Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
    By Frank Vinluan - Wednesday Jun 14, 2017

    The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]

    Source: Xconomy New York